Spring 2024 Prime Therapeutics Report - Prime Therapeutics
Spring 2024 Prime Therapeutics Report
Single-Treatment Gene Therapies and Proper Management
The 2024 Medicaid Pharmacy Trend Report offers insights into the gross and net drug spend trends across Medicaid programs through the previous year. Using the Medicaid Fee-for-Service (FFS) space to the achieve the highest level of accuracy for trend reporting, our annual report details traditional and specialty drug spend and impact, the top classes and individual drugs driving trend, as well as a closer look into the top driver of Medicaid net spend.
The Medicaid Pharmacy Economics section, included in every issue of the report, provides the fundamental background for new readers and those who need a refresher on the calculation of the federal rebate and the impact rebates have on the net price of drugs in the Medicaid program.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.